1,305
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus

ORCID Icon, , , ORCID Icon, &
Pages 857-871 | Received 08 Apr 2020, Accepted 08 Jul 2020, Published online: 05 Aug 2020

References

  • Ritchie H, Roser M Causes of Death. Published online at OurWorldInData.org. 2020. Retrieved from: https://ourworldindata.org/causes-of-death [accessed: 06 April, 2020]
  • Purcell RH, Emerson SU. Hepatitis E virus, p. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE editors. Fields virology. 4th. Philadelphia (Pa): Lippincott Williams and Wilkins; 2001. p. 3051–61.
  • Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9):1484–93. doi:10.1111/j.1440-1746.2009.05933.x.
  • Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res. 2011;161(1):23–30. doi:10.1016/j.virusres.2011.01.016.
  • Meng XJ, Shivaprasad HL, Payne C. Hepatitis E virus infections. In: Saif M, Fadly AM, Glisson JR, McDougald LR, Nolan LK, Swayne DE, editors. Diseases of Poultry. 12th. Ames, Iowa: Blackwell Publishing Press; 2008. p. 443–52.
  • Pavio N, Meng XJ, Renou C. Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res. 2010;41(6):46. doi:10.1051/vetres/2010018.
  • Kamar N, Bendall R, Legrand-Abravanel F, Xia N-S, Ijaz S, Izopet J, Dalton HR. Hepatitis E [published correction appears in. Lancet. 2012 Aug 25;380(9843):730]. Lancet. 2012;379(9835):2477–2488. doi:10.1016/S0140-6736(11)61849-7.
  • World Health Organization (WHO). What is Hepatitis? Retrieved from: https://www.who.int/features/qa/76/en/ [accessed:06 April, 2020]
  • World Health Organization (WHO), Hepatitis E. 8 July 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e [accessed: 07 April, 2020]
  • Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Zoonotic Diseases. Page last reviewed: July 14, 2017. Retrieved from: https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html [accessed: 06 April, 2020].
  • Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, Berg T, Hofmann J. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56(2):500–02. doi:10.1016/j.jhep.2011.06.021.
  • Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy ITR, Kitchen A, Patel P, Poh J, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384(9956):1766–73. doi:10.1016/S0140-6736(14)61034-5.
  • Matsui T, Kang JH, Matsubayashi K, Yamazaki H, Nagai K, Sakata H, Tsuji K, Maguchi H. Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res. 2015;45(6):698–704. doi:10.1111/hepr.12390.
  • Smith DB, Simmonds P, Jameel S, Emerson SU, Harrison TJ, Meng X-J, Okamoto H, Van der Poel WHM, Purdy MA; Members Of The International Committee On The Taxonomy Of Viruses Hepeviridae Study Group. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2015;96(5):1191–92. doi:10.1099/vir.0.000115.
  • Hartl J, Wehmeyer MH, Pischke S. Acute Hepatitis E: two Sides of the Same Coin. Viruses. 2016;8(11):299. doi:10.3390/v8110299.
  • Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859–60. doi:10.1056/NEJMc0708687.
  • Modiyinji AF, Amougou‐Atsama M, Monamele CG, Nola M, Njouom R. Seroprevalence of hepatitis E virus antibodies in different human populations of Cameroon. J Med Virol. 2019;91(11):1989–94. doi:10.1002/jmv.25545.
  • Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013;33(1):41–49. doi:10.1055/s-0033-1338113.
  • Kenney SP, Meng XJ. Hepatitis E Virus: animal Models and Zoonosis. Annu Rev Anim Biosci. 2019;7:427–48. doi:10.1146/annurev-animal-020518-115117.
  • Niikura M, Takamura S, Kim G, Kawai S, Saijo M, Morikawa S, Kurane I, Li T-C, Takeda N, Yasutomi Y, et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology. 2002;293(2):273–80. doi:10.1006/viro.2001.1240.
  • Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33(4):451–64. doi:10.1007/s12038-008-0064-1.
  • Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res. 2011;161(1):47–58. doi:10.1016/j.virusres.2011.02.011.
  • Tam AW, Smith MM, Guerra ME, Huang -C-C, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185(1):120–31. doi:10.1016/0042-6822(91)90760-9.
  • Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70:597–604.
  • Teshale EH, Grytdal SP, Howard C, Barry V, Kamili S, Drobeniuc J, Hill V, Okware S, Hu D, Holmberg S, et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis. 2010;50(7):1006–10. doi:10.1086/651077.
  • Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol. 2004;23:59–62.
  • Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, Kumar Panda S. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387–94. doi:10.1016/j.jhep.2006.09.016.
  • World Health Organization. Waterborne Outbreaks of Hepatitis E: recognition, Investigation and Control. Geneva, Switzerland: World Health Organization; 2014. ISBN: 9789241507608
  • Browne LB, Menkir Z, Kahi V, Maina G, Asnakew S, Tubman M, Elyas HZ, Nigatu A, Dak D, Maung UA, et al. Notes from the field: hepatitis E outbreak among refugees from South Sudan - Gambella, Ethiopia, April 2014-January 2015. MMWR Morb Mortal Wkly Rep. 2015;64(19):537.
  • Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980;68(6):818–24. doi:10.1016/0002-9343(80)90200-4.
  • Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980;2(8200):876–79. doi:10.1016/s0140-6736(80)92045-0.
  • Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23–31. doi:10.1159/000149370.
  • Reyes GR, Huang CC, Tam AW, Purdy MA. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl. 1993;7:15–25. doi:10.1007/978-3-7091-9300-6_2.
  • Bradley DW. Hepatitis E virus: a brief review of the biology, molecular virology, and immunology of a novel virus. J Hepatol. 1995;22(1 Suppl):140–45. Holla RP, Ahmad I, Ahmad Z, Jameel S. Molecular virology of hepatitis E virus. Semin Liver Dis. 2013;33(1):3–14. doi:10.1055/s-0033-1338110
  • Guu TS, Liu Z, Ye Q, Mata DA, Li K, Yin C, Zhang J, Tao YJ. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A. 2009;106(31):12992–97. doi:10.1073/pnas.0904848106.
  • Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988–97. doi:10.1002/hep.25505.
  • Dalton HR, Bendall R, Ijaz S, Banks M. E: hepatitis an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698–709. doi:10.1016/S1473-3099(08)70255-X.
  • Hartl J, Otto B, Madden RG, Webb G, Woolson K, Kriston L, Vettorazzi E, Lohse A, Dalton H, Pischke S, et al. Hepatitis E Seroprevalence in Europe: A Meta-Analysis. Viruses. 2016;8(8):211. doi:10.3390/v8080211.
  • Capai L, Falchi A, Charrel R. Meta-Analysis of Human IgG anti-HEV Seroprevalence in Industrialized Countries and a Review of Literature. Viruses. 2019;11(1):84. doi:10.3390/v11010084.
  • Scotto G, Martinelli D, Centra M, Querques M, Vittorio F, Carri PD, Tartaglia A, Campanale F, Bulla F, Prato R, et al. Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy). Epidemiol Infect. 2014;142(2):287–94. doi:10.1017/S0950268813001167.
  • Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17(12):2309–12. doi:10.3201/eid1712.110371.
  • Dalekos GN, Zervou E, Elisaf M, Germanos N, Galanakis E, Bourantas K, Siamopoulos KC, Tsianos EV. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion. 1998;38(6):589–95. doi:10.1046/j.1537-2995.1998.38698326339.x.
  • Sylvan SP, Jacobson SH, Christenson B. Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden. J Med Virol. 1998;54(1):38–43. doi:10.1002/(SICI)1096-9071(199801)54:1<38::AID-JMV6>3.0.CO;2-Q.
  • Stefanidis I, Zervou EK, Rizos C, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Rigopoulou EI, Liakopoulos V, et al. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs. 2004;27(10):842–47. doi:10.1177/039139880402701005.
  • Mitsui T, Tsukamoto Y, Hirose A, Suzuki S, Yamazaki C, Masuko K, Tsuda F, Endo K, Takahashi M, Okamoto H, et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol. 2006;78(8):1015–24. doi:10.1002/jmv.20657.
  • Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl. 1997;62:S79–S82.
  • Litjens NH, Huisman M, van den Dorpel M, Betjes MG. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol. 2008;19(8):1483–90. doi:10.1681/ASN.2007090971.
  • Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology (Carlton). 2010;15(2):137–45. doi:10.1111/j.1440-1797.2009.01268.x.
  • Scotto G, Aucella F, Grandaliano G, Martinelli D, Querques M, Gesuete A, Infante B, Carri PD, Massa S, Salatino G, et al. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy. World J Gastroenterol. 2015;21(11):3266–73. doi:10.3748/wjg.v21.i11.3266.
  • Bergløv A, Hallager S, Weis N. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes-A systematic review. J Viral Hepat. 2019;26(11):1240–48. doi:10.1111/jvh.13129.
  • Li M, Li S, He Q, Liang Z, Wang L, Wang Q, Wang L. Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model. Emerg Microbes Infect. 2019;8(1):1066–75. doi:10.1080/22221751.2019.1643260.
  • Li M, Bu Q, Gong W, Li H, Wang Li, Li S, Sridhar S, Woo P CY, Wang L. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China [published online ahead of print, 2019 Feb 27]. J Matern Fetal Neonatal Med. 2019;1–5. doi:10.1080/14767058.2019.1582630.
  • Ahmad T, Hui J, Musa TH, Behzadifar M, Baig M. Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. Ann Saudi Med. 2020;40(2):136–46. doi:10.5144/0256-4947.2020.136.
  • Shrestha S. Hepatitis E in Nepal. Kathmandu Univ Med J. 2006;4:530–44.
  • Dilawari JB, Singh K, Chawla YK, Ramesh GN, Chauhan A, Bhusnurmath SR, Sharma TR, Sokhey CS. Hepatitis E virus: epidemiological, clinical and serological studies of north Indian epidemic. Indian J Gastroenterol. 1994;13:44–48.
  • Khuroo MS, Hepatitis E. the enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol. 1991;10:96–100.
  • Bile K, Isse A, Mohamud O, Mushahwar IK, Magnius LO, Bile K, Isse A, Mohamud O. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg. 1994;51(4):466–74. doi:10.4269/ajtmh.1994.51.466.
  • Lubis I. Outbreak of hepatitis E in West Kalimantan. Cermin Dunia Kedokteran. 1994;95:43‐46.
  • Mast E, Polish LB, Favorov MO, Khudyakova NS, Collins C, Tukei PM, Koptich D, Khudyakov YE, Fields HA, Margolis HS. Hepatitis E among refugees in Kenya: minimal apparent person‐to‐person transmission, evidence for age‐dependent disease expression, and new serological assays. In: Kishioka K, Suzuki H, Mishiro S, Oda T, editors. Viral Hepatitis and Liver Disease. Tokyo, Japan: Springer‐Verlag; 1994. 375‐378. doi:10.1007/978-4-431-68255-4
  • Coursaget P, Buisson Y, Enogat N, Bercion R, Baudet J-M, Delmaire P, Prigent D, Desramé J. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol. 1998;28(5):745–50. doi:10.1016/s0168-8278(98)80222-5.
  • Rab MA, Bile MK, Mubarik MM, Asghar H, Sami Z, Siddiqi S, Dil AS, Barzgar MA, Chaudhry MA, Burney MI. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg. 1997;57(2):151–57. doi:10.4269/ajtmh.1997.57.151.
  • Goumba AI, Konamna X, Komas NP. Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic. BMC Infect Dis. 2011 Published 2011 Apr 14;11:93. doi:10.1186/1471-2334-11-93.
  • Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, Nizou J-Y, Nicand E, Guerin PJ. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis. 2006;42(12):1679–84. doi:10.1086/504322.
  • Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, Drobeniuc J, Okware S, Downing R, Tappero JW, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis. 2010;16(1):126–29. doi:10.3201/eid1601.090764.
  • International Centre for Diarrhoeal Disease Research, Bangladesh. Outbreak of hepatitis E in a low income urban community in Bangladesh. Health Sciences Bulletin 2009;7:14‐20.
  • International Centre for Diarrhoeal Disease Research, Bangladesh. Hepatitis E outbreak in Rajshahi City Corporation. Health Science Bulletin 2010;8:12‐18.
  • Rayis DA, Jumaa AM, Gasim GI, Karsany MS, Adam I. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health. 2013;107(2):66–68. doi:10.1179/2047773213Y.0000000076.
  • Agarwal S, Anuradha SA, Sahoo AB, Duggal N. Seroprevalence of Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) Co-infection in the Patients Presenting with Acute Viral Hepatitis Attending a Tertiary Care Hospital in North India. J Commun Dis. 2017;49(3):57–60. doi:10.24321/0019.5138.201723.
  • Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J Viral Hepat. 2001;8(4):293–303. doi:10.1046/j.1365-2893.2001.00279.x.
  • Emerson SU, Purcell RH. Running like water–the omnipresence of hepatitis E. N Engl J Med. 2004;351(23):2367–68. doi:10.1056/NEJMp048285.
  • Al-Sadeq DW, Majdalawieh AF, Mesleh AG, Abdalla OM, Nasrallah GK. Laboratory challenges in the diagnosis of hepatitis E virus. J Med Microbiol. 2018;67(4):466–80. doi:10.1099/jmm.0.000706.
  • Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology. 2012;142(6):1388–1397.e1. doi:10.1053/j.gastro.2012.02.014.
  • Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011;52(1):60–62. doi:10.1016/j.jcv.2011.06.004.
  • Melgaço JG, Gardinali NR, de Mello VDM, Leal M, Lewis-Ximenez LL, Pinto MA. Hepatitis E: update on Prevention and Control. Biomed Res Int. 2018;2018:5769201. doi:10.1155/2018/5769201.
  • Goumba CM, Yandoko-Nakouné ER, Komas NP. A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes. 2010 Published 2010 Apr 15;3:103. doi:10.1186/1756-0500-3-103.
  • Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014;65(1):95–104. doi:10.1016/j.cyto.2013.09.022.
  • Domanović D, Tedder R, Blümel J, Zaaijer H, Gallian P, Niederhauser C, Sauleda Oliveras S, O’Riordan J, Boland F, Harritshøj L, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22(16):30514. doi:10.2807/1560-7917.ES.2017.22.16.30514.
  • Lapa D, Capobianchi MR, Garbuglia AR. Epidemiology of Hepatitis E Virus in European Countries. Int J Mol Sci. 2015 [Published 2015 Oct 27];16(10):25711–43. doi:10.3390/ijms161025711.
  • Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother. 2015;11(4):908–14. doi:10.1080/21645515.2015.1008870.
  • Trabelsi K, Kamen A, Kallel H. Development of a vectored vaccine against hepatitis E virus. Vaccine. 2014;32(24):2808–11. doi:10.1016/j.vaccine.2014.02.041.
  • Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N, Myint KSA, Fourneau M, Kuschner RA, Shrestha SK, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356(9):895–903. doi:10.1056/NEJMoa061847.
  • Zhu FC, Zhang J, Zhang XF, Zhou C, Wang -Z-Z, Huang S-J, Wang H, Yang C-L, Jiang H-M, Cai J-P, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376(9744):895–902. doi:10.1016/S0140-6736(10)61030-6.
  • Riedmann EM. Chinese biotech partnership brings first hepatitis E vaccine to the market. Hum Vaccin Immunother. 2012;8(12):1743–44. doi:10.4161/hv.23373.
  • Zaman K, Dudman S, Stene-Johansen K, Qadri F, Yunus M, Sandbu S, Gurley ES, Overbo J, Julin CH, Dembinski JL, et al. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open. 2020;10(1):e033702. doi:10.1136/bmjopen-2019-033702.
  • Park SB. Hepatitis E vaccine debuts. Nature. 2012;491(7422):21–22. doi:10.1038/491021a.
  • Wu X, Chen P, Lin H, Hao X, Liang Z. Hepatitis E virus: current epidemiology and vaccine. Hum Vaccin Immunother. 2016;12(10):2603–10. doi:10.1080/21645515.2016.1184806.
  • Loomes DE, van Zanten SV. Bibliometrics of the top 100 clinical articles in digestive disease. Gastroenterology. 2013;144(4):673–676.e5. doi:10.1053/j.gastro.2013.02.013.
  • Wani ZA, Kharadi AH, Ganaie M. Bibliometric analysis of ‘Hepatitis E’ literature. IJIDT. 2017;7(4):242–46. doi:10.5958/2249-5576.2017.00032.2.
  • Sangam SL, Arali UB, Patil CG, Rousseau R. Growth of the hepatitis literature over the period 1976–2015: what can the relative priority index teach us? Scientometrics. 2018;115(1):351–68. doi:10.1007/s11192-018-2668-z.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.